Our study demonstrated that ARID3A was highly expressed in ABC subtype DLBCL patients and cell lines, and the overexpression of ARID3A facilitated the proliferation of GCB DLBCL cells and inhibited cell apoptosis. The gene discussed is ARID3A; the disease is diffuse large B-cell lymphoma.